Misbah Tahir - 14 May 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Financial Officer
Signature
/s/ Misbah Tahir
Issuer symbol
IGMS
Transactions as of
14 May 2021
Transactions value $
$2,066
Form type
4
Date filed
18 May 2021, 21:42
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $2.07K +45 +0.81% $45.90 5.59K 14 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).